These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 7527374

  • 21. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
    van Zonneveld M, Honkoop P, Hansen BE, Niesters HG, Darwish Murad S, de Man RA, Schalm SW, Janssen HL.
    Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
    [Abstract] [Full Text] [Related]

  • 22. Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis B.
    Stancek D, Hajnická V, Blaskovicová H, Sudová J, Laktis K, Janota S, Jezek P.
    Acta Virol; 1990 Sep; 34(5):457-66. PubMed ID: 1981456
    [Abstract] [Full Text] [Related]

  • 23. Treatment of chronic hepatitis type virus B.
    Schalm SW.
    Hepatogastroenterology; 1984 Feb; 31(1):12-6. PubMed ID: 6199273
    [Abstract] [Full Text] [Related]

  • 24. [Interferon treatment of chronic viral hepatitis].
    Pirovino M.
    Ther Umsch; 1992 May; 49(5):302-9. PubMed ID: 1377840
    [Abstract] [Full Text] [Related]

  • 25. [Virostatic therapy of chronic hepatitis].
    Müller R, Klein H, Niehoff G.
    Z Gesamte Inn Med; 1988 Dec 15; 43(24):705-10. PubMed ID: 2467448
    [Abstract] [Full Text] [Related]

  • 26. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
    Hess G, Weber C, Rossol S, Voth R, Drees N, Meyer zum Büschenfelde KH.
    Z Gastroenterol; 1988 Jul 15; 26(7):380-7. PubMed ID: 3223006
    [Abstract] [Full Text] [Related]

  • 27. Approaches to the treatment of chronic hepatitis B viral infection.
    Thomas HC, Lok AS.
    Prog Clin Biol Res; 1983 Jul 15; 143():379-93. PubMed ID: 6199798
    [Abstract] [Full Text] [Related]

  • 28. Human lymphoblastoid interferon therapy in chronic hepatitis B virus carriers.
    Alexander GJ.
    Chemioterapia; 1988 Dec 15; 7 Suppl 3():9-11. PubMed ID: 3248319
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Modification of hepatitis B virus infection by recombinant leukocyte alpha A interferon.
    Hess G, Meyer zum Büschenfelde KH.
    Immunobiology; 1986 Sep 15; 172(3-5):255-61. PubMed ID: 3643162
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Immunological aspects of acute viral hepatitis treated with corticosteroids].
    Singeisen M, Stalder GA, Bianchi L, Gudat F, Schmid M.
    Schweiz Med Wochenschr; 1977 Dec 03; 107(48):1762-4. PubMed ID: 929138
    [Abstract] [Full Text] [Related]

  • 39. Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect metanalysis.
    Cohard M, Poynard T, Mathurin P, Zarski JP.
    Hepatology; 1994 Dec 03; 20(6):1390-8. PubMed ID: 7527000
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.